Ron DeSantis Goes VIRAL For Telling Kids That Masks Are Optional At Press Conference
https://www.facebook.com/An0malyMusic/videos/523954155900668/?notif_id=1646190764441893¬if_t=live_video_explicit&ref=notif
https://www.facebook.com/An0malyMusic/videos/523954155900668/?notif_id=1646190764441893¬if_t=live_video_explicit&ref=notif
Treatments
Tablet Readyる.
|
Tablet Ready
|
Courses
|
Canadian Health Minister Dismisses Peer-Reviewed Studies on Vitamin D as 'Fake News'. Apr 23, 2021 (https://www.youtube.com/watch?v=-SCAZEEYSTs)
|
Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2) https://www.youtube.com/watch?v=ha2mLz-Xdpg
Roger Seheult, MD is Co-Founder of MedCram and an Associate Professor at the University of California, Riverside School of Medicine and Assistant Prof. at Loma Linda University School of Medicine. He is Quadruple Board Certified: Internal Medicine, Pulmonary Disease, Critical Care, & Sleep Medicine. |
.
|
observational studies suggest that when you compare two doses of vaccine with natural immunity it seems to be equal, if not better for natural immunity
The reinfection can happen three months after your first infection because many patients have a viral shedding for several weeks, and months. |
There's much more to the immune response system than just the antibodies, vitamin D Levels, lifestyle choices, ...,
- Dr. Zelenko’s Anti-Shedding Treatment. NOW AVAILABLE FOR KIDS. http://zStackProtocol.com
- Oral antiviral treatment (for not fully vaccinated) works by targeting specific proteins on the SARS-CoV-2 virus to prevent efficient virus replication within the host cell. Paxlovid and molnupiravir reduce the risk of hospitalization and death by 88% and 30% respectively, in patients at high-risk for severe COVID-19 when started early after symptom onset. Apocalypse.pdf
New Monoclonal Antibody Drbeen Medical Lectures https://www.youtube.com/watch?v=2Uhnjg6kSpI Feb 11, 2022 Drbeen Medical Lectures
|
|
China approves use of Pfizer's COVID drug Paxlovid
Paxlovid: China approves Pfizer COVID drug | CTV News
Paxlovid: China approves Pfizer COVID drug | CTV News
PAXLOVID is not approved for any use, including for use as treatment
of COVID-19. (1) PAXLOVID is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of PAXLOVID under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner . HIV-1 Drug Resistance: PAXLOVID use may lead to a risk of HIV-1 developing resistance to HIV protease inhibitors in individuals with uncontrolled or undiagnosed HIV-1 infection. (5.3) . FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVIDTM https://www.fda.gov/media/155050/download |
These three oral antiviral drugs are still being studied:
. Molnupiravir: https://www.fda.gov/media/155055/download?ftag=MSF0951a18 . Fluvoxamine https://www.drugs.com/mtm/fluvoxamine.html . PAXLOVID https://www.fda.gov/media/155051/download . A meta-analysis was conducted for three new oral antivirals to evaluate the improvement in mortality or hospitalization rates and adverse events among COVID-19 patients. |
Results
A total of eight studies were included in this study. The Drug Group: - included 2440 COVID-19 patients , including 54 patients who died or were hospitalized . The Control Group: - included a total of 2348 COVID-19 patients - including 118 patients who died or were hospitalized These results indicate that oral antiviral drugs were effective "For COVID-19 patients and reduced the mortality or hospitalization by approximately 67%. Full article: Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis (tandfonline.com) |
‘No evidence of benefit’: FDA says hydroxychloroquine no longer approved for Covid-19 emergency use https://www.rt.com/usa/491919-fda-hydroxychloroquine-emergency-revoked/
US regulators have revoked emergency approval for the use of hydroxychloroquine to treat Covid-19. Doctors will still be able to prescribe the drug, recently taken by President Donald Trump himself, for off-label use.
Citing the “totality of scientific evidence available,” Food and Drug Administration (FDA) Chief Scientist Denise M. Hinton wrote on Monday that it was “no longer reasonable to believe” that hydroxychloroquine (HCQ) and chloroquine (CQ) may be effective against the novel coronavirus, as outlined in the emergency authorization EUA 039 from April 2020.
I’ve lost all trust in medical research – the financial muscle of Big Pharma has been busy distorting science during the pandemic
US regulators have revoked emergency approval for the use of hydroxychloroquine to treat Covid-19. Doctors will still be able to prescribe the drug, recently taken by President Donald Trump himself, for off-label use.
Citing the “totality of scientific evidence available,” Food and Drug Administration (FDA) Chief Scientist Denise M. Hinton wrote on Monday that it was “no longer reasonable to believe” that hydroxychloroquine (HCQ) and chloroquine (CQ) may be effective against the novel coronavirus, as outlined in the emergency authorization EUA 039 from April 2020.
I’ve lost all trust in medical research – the financial muscle of Big Pharma has been busy distorting science during the pandemic
|
Ivermectin trial, Oxford University
https://www.youtube.com/watch?v=c9bgCG5WgTQ Dr. John Campbell MedPage Today, Merck "concluded that the probability of ivermectin providing a potentially safe and efficacious treatment option for SARS-CoV-2 infection is low and have prioritized internal efforts towards the development of alternate candidates that provide a higher probability of success for the treatment of COVID-19." "If clinical data emerge providing definitive evidence for a positive benefit-risk assessment of the use of ivermectin in COVID-19, we stand ready to provide our expertise and resources as needed," |